Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Elixir Department: SOP for Use of Water for Injection (WFI) in Elixir Production – V 2.0

Posted on By

Elixir Department: SOP for Use of Water for Injection (WFI) in Elixir Production – V 2.0

Standard Operating Procedure for Use of Water for Injection (WFI) in Elixir Production

Department Elixir Department
SOP No. SOP/ELX/058/2025
Supersedes SOP/ELX/058/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To establish a standard procedure for the use, handling, and quality control of Water for Injection (WFI) in the manufacturing of elixir formulations to ensure compliance with GMP requirements.

2. Scope

This SOP applies to all activities involving the collection, transfer, usage, and documentation of WFI in elixir manufacturing in the Elixir Department.

3. Responsibilities

  • Production Operator:
    • Collect and use WFI in accordance with batch requirements and specifications.
    • Ensure proper line flushing and container sanitization before collection.
  • Production Supervisor:
    • Verify WFI collection process and temperature.
    • Monitor that WFI is used within the hold time limit.
  • QA Officer:
    • Perform sampling and release of WFI prior to use.
    • Ensure all WFI usage is traceable in documentation.
See also  Elixir Department: SOP for Handling Material Return Post Dispensing - V 2.0

4. Accountability

The Production Head is accountable for ensuring that WFI is used as per specifications and no microbial or endotoxin risk is introduced into the batch.

5. Procedure

5.1 WFI Collection

  1. Ensure the WFI loop is in validated state and operating above 80°C in circulation mode.
  2. Flush the sampling point or user valve for at least 2 minutes before collection.
  3. Sanitize the outer nozzle of the user point with 70% IPA.
  4. Collect WFI in pre-cleaned, stainless steel or HDPE containers labeled with:
    • “WFI – For Manufacturing Use Only”
    • Date and Time of Collection
    • Collected By

5.2 Quality Control of WFI

  1. Send samples to QC for analysis of the following:
    • Conductivity
    • Total Organic Carbon (TOC)
    • Microbial Load
    • Endotoxin Level (if applicable)
  2. WFI shall be used only after release by QA based on results.
See also  Elixir Department: SOP for Handling Damaged Raw Material Packs - V 2.0

5.3 Usage Guidelines

  1. Use WFI only within 4 hours of collection if stored below 25°C, or within 8 hours if maintained at ≥70°C.
  2. Do not reuse WFI from previous batches.
  3. Document the WFI quantity used, batch number, and time in the BMR and WFI Usage Log (Annexure-1).

5.4 Cleaning After Use

  1. Clean and dry all WFI collection containers after use.
  2. Label containers as “Cleaned” with date and signature.

6. Abbreviations

  • WFI: Water for Injection
  • TOC: Total Organic Carbon
  • QA: Quality Assurance
  • SOP: Standard Operating Procedure
  • BMR: Batch Manufacturing Record

7. Documents

  1. WFI Usage Log (Annexure-1)
  2. WFI Sampling and Test Report (Annexure-2)
  3. WFI Container Cleaning Log (Annexure-3)

8. References

  • USP Monograph on Water for Injection
  • WHO TRS 970 – Annex 2: Pharmaceutical Water Systems
  • 21 CFR Part 211.110 – Sampling and Testing
See also  Elixir Department: SOP for Environmental Monitoring of Dispensing Area - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: WFI Usage Log

Date Batch No. WFI Qty (L) Time Collected Used By Verified By
11/04/2025 ELX-1004 100 09:00 AM Rajesh Kumar Sunita Reddy

Annexure-2: WFI Sampling and Test Report

Parameter Limit Result Status
Conductivity < 1.3 µS/cm 0.9 µS/cm Pass
TOC < 500 ppb 320 ppb Pass
Microbial Load < 10 CFU/100 mL 2 CFU Pass

Annexure-3: WFI Container Cleaning Log

Date Container ID Cleaned By Verified By Status
11/04/2025 WFI-C-01 Ajay Desai Manju Sharma Cleaned

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Issue New SOP QA Head
11/04/2025 2.0 Added TOC Testing and Hold Time Limits Regulatory Compliance QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: BA-BE Studies: SOP for Emergency Protocol Activation – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version